Skip to content
Loading…
As of this week in Montana, any biotech company with an experimental drug has a clear path to selling it to consumers. Companies whose drugs have been through preliminary testing—sometimes in as few as 10 healthy people—can pay $12,500 to apply to a newly established review…
To respect copyright, we link to the source rather than republishing the full text. Read the complete article on MIT Technology Review.